Skip to content

Insider · CIK 0001818576

Rankin Aubrey

Reports to the SEC for 1 company · NEWARK, CA

Transactions

22

Companies

1

Filings

15

CIK

0001818576

Forms 4 and 5

Insider transactions

22 trades
DateCompanyValue
2022-03-15Revance Therapeutics, Inc.F Tax Payment−$21.7K
2021-12-03Revance Therapeutics, Inc.P Purchase+$433K
2021-08-16Revance Therapeutics, Inc.S Sale−$247K
2021-08-15Revance Therapeutics, Inc.F Tax Payment−$129K
2021-07-28Revance Therapeutics, Inc.S Sale−$1.03M
2021-07-28Revance Therapeutics, Inc.S Sale−$603K
2021-07-26Revance Therapeutics, Inc.S Sale−$1.65M
2021-04-05Revance Therapeutics, Inc.S Sale−$56.56
2021-03-04Revance Therapeutics, Inc.S Sale−$842K
2021-02-02Revance Therapeutics, Inc.A Award—
2021-02-02Revance Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award—
2021-02-01Revance Therapeutics, Inc.S Sale−$859K
2020-12-30Revance Therapeutics, Inc.S Sale−$921K
2020-11-30Revance Therapeutics, Inc.S Sale−$790K
2020-10-29Revance Therapeutics, Inc.S Sale−$866K
2020-09-28Revance Therapeutics, Inc.S Sale−$867K
2020-07-23Revance Therapeutics, Inc.A Award—
2020-07-23Revance Therapeutics, Inc.A Award—
2020-07-23Revance Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award+$114K
2020-07-23Revance Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award+$22.5K
2020-07-23Revance Therapeutics, Inc.A Award—
2020-07-23Revance Therapeutics, Inc.A Award—

Recent filings

15

Companies

1

Address

C/O REVANCE THERAPEUTICS, INC 7555 GATEWAY BLVD

NEWARK, CA, 94560